Dana G Smith
TitleCited byYear
Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry
TW Robbins, CM Gillan, DG Smith, S de Wit, KD Ersche
Trends in cognitive sciences 16 (1), 81-91, 2012
5802012
The neurobiological underpinnings of obesity and binge eating: a rationale for adopting the food addiction model
DG Smith, TW Robbins
Biological psychiatry 73 (9), 804-810, 2013
2372013
Arterial embolization in the management of posterior epistaxis
NP Christensen, DS Smith, SL Barnwell, MK Wax
Otolaryngology–Head and Neck Surgery 133 (5), 748-753, 2005
1262005
Decision making in children and adolescents: Impaired Iowa Gambling Task performance in early adolescence.
DG Smith, L Xiao, A Bechara
Developmental psychology 48 (4), 1180, 2012
1192012
The metabolism and elimination of d-tubocurarine-H3
E Cohen, HW Brewer, D Smith
Anesthesiology 28 (2), 309-317, 1967
1071967
Distinctive personality traits and neural correlates associated with stimulant drug use versus familial risk of stimulant dependence
KD Ersche, PS Jones, GB Williams, DG Smith, ET Bullmore, TW Robbins
Biological psychiatry 74 (2), 137-144, 2013
1012013
Enhanced orbitofrontal cortex function and lack of attentional bias to cocaine cues in recreational stimulant users
DG Smith, PS Jones, ET Bullmore, TW Robbins, KD Ersche
Biological psychiatry 75 (2), 124-131, 2014
332014
Surgical outcomes for velopharyngeal insufficiency in velocardiofacial syndrome and nonsyndromic patients
HA Milczuk, DS Smith, JH Brockman
The Cleft palate-craniofacial journal 44 (4), 412-417, 2007
272007
Aberrant disgust responses and immune reactivity in cocaine-dependent men
KD Ersche, CC Hagan, DG Smith, S Abbott, PS Jones, ...
Biological psychiatry 75 (2), 140-147, 2014
242014
Cognitive control dysfunction and abnormal frontal cortex activation in stimulant drug users and their biological siblings
DG Smith, PS Jones, ET Bullmore, TW Robbins, KD Ersche
Translational psychiatry 3 (5), e257, 2013
222013
The Imperial College Cambridge Manchester (ICCAM) platform study: an experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: study …
LM Paterson, RSA Flechais, A Murphy, LJ Reed, S Abbott, V Boyapati, ...
Journal of Psychopharmacology 29 (9), 943-960, 2015
202015
Impulsivity in abstinent alcohol and polydrug dependence: a multidimensional approach
EM Taylor, A Murphy, V Boyapati, KD Ersche, R Flechais, S Kuchibatla, ...
Psychopharmacology 233 (8), 1487-1499, 2016
182016
Risk of uterine rupture among women attempting vaginal birth after cesarean with an unknown uterine scar
D Smith, E Stringer, CJ Vladutiu, AH Zink, R Strauss
American journal of obstetrics and gynecology 213 (1), 80. e1-80. e5, 2015
182015
Acute naltrexone does not remediate fronto‐striatal disturbances in alcoholic and alcoholic polysubstance‐dependent populations during a monetary incentive delay task
LJ Nestor, A Murphy, J McGonigle, C Orban, L Reed, E Taylor, R Flechais, ...
Addiction biology 22 (6), 1576-1589, 2017
132017
Overlapping decline in orbitofrontal gray matter volume related to cocaine use and body mass index
DG Smith, PS Jones, GB Williams, ET Bullmore, TW Robbins, KD Ersche
Addiction biology 20 (1), 194-196, 2015
132015
Using a drug-word Stroop task to differentiate recreational from dependent drug use
DG Smith, KD Ersche
CNS spectrums 19 (3), 247-255, 2014
122014
Naltrexone ameliorates functional network abnormalities in alcohol‐dependent individuals
LS Morris, K Baek, R Tait, R Elliott, KD Ersche, R Flechais, J McGonigle, ...
Addiction biology 23 (1), 425-436, 2018
102018
Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery
G Savulich, R Riccelli, L Passamonti, M Correia, JFW Deakin, R Elliott, ...
Translational psychiatry 7 (3), e1054, 2017
92017
In the face of threat: neural and endocrine correlates of impaired facial emotion recognition in cocaine dependence
KD Ersche, CC Hagan, DG Smith, PS Jones, AJ Calder, GB Williams
Translational psychiatry 5 (5), e570, 2015
92015
The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description
J McGonigle, A Murphy, LM Paterson, LJ Reed, L Nestor, J Nash, R Elliott, ...
Journal of Psychopharmacology 31 (1), 3-16, 2017
72017
The system can't perform the operation now. Try again later.
Articles 1–20